OMERS Administration Corp’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,429
Closed -$9.39M 971
2026
Q1
$9.39M Sell
54,429
-4,100
-7% -$760K 0.06% 148
2025
Q4
$11.7M Buy
58,529
+8,000
+16% +$1.45M 0.08% 106
2025
Q3
$7.91M Hold
50,529
0.06% 138
2025
Q2
$7.67M Hold
50,529
0.06% 131
2025
Q1
$7.61M Sell
50,529
-304
-0.6% -$51K 0.07% 128
2024
Q4
$9.38M Buy
50,833
+357
+0.7% +$68.8K 0.08% 109
2024
Q3
$9.94M Buy
50,476
+11,800
+31% +$2.45M 0.09% 112
2024
Q2
$7.99M Buy
+38,676
New +$8.76M 0.08% 122
2018
Q1
Sell
-30,100
Closed -$3.29M 436
2017
Q4
$3.29M Buy
+30,100
New +$3.28M 0.03% 197
2016
Q4
Sell
-42,300
Closed -$3.52M 375
2016
Q3
$3.52M Sell
42,300
-4,700
-10% -$394K 0.06% 175
2016
Q2
$3.88M Sell
47,000
-3,600
-7% -$297K 0.08% 163
2016
Q1
$3.84M Hold
50,600
0.09% 151
2015
Q4
$4.07M Sell
50,600
-2,700
-5% -$195K 0.11% 155
2015
Q3
$3.39M Hold
53,300
0.1% 157
2015
Q2
$3.75M Buy
+53,300
New +$3.94M 0.15% 147
2014
Q2
Sell
-249,800
Closed -$15.1M 384
2014
Q1
$15.1M Sell
249,800
-362,900
-59% -$21.2M 0.49% 50
2013
Q4
$32.5M Buy
+612,700
New +$30.8M 1.19% 26

Other funds holding CRL

OMERS Administration Corp's CRL Position: Q2 2026 in Review

OMERS Administration Corp sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 54,429 shares — an estimated $9.39M sold.

OMERS Administration Corp first reported a position in CRL in Q4 2013 and held it in 17 quarters. The position peaked at $32.5M in Q4 2013. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • OMERS Administration Corp reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 54,429 Charles River Laboratories shares in Q2 2026, an estimated $9.39M.
  • OMERS Administration Corp first reported a position in Charles River Laboratories in Q4 2013 and held it in 17 quarters.
  • OMERS Administration Corp's Charles River Laboratories position peaked at $32.5M in Q4 2013.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.